APA (7th ed.) Citation

Feng, R., Zhang, X., & He, J. (2025). Combination therapy with belimumab and low‐dose interleukin‐2 in a patient with anti‐MDA5 antibody dermatomyositis overlapping with systemic lupus erythematosus. Rheumatology & Autoimmunity, 5(1), 73. https://doi.org/10.1002/rai2.12154

Chicago Style (17th ed.) Citation

Feng, Ruiling, Xia Zhang, and Jing He. "Combination Therapy with Belimumab and Low‐dose Interleukin‐2 in a Patient with Anti‐MDA5 Antibody Dermatomyositis Overlapping with Systemic Lupus Erythematosus." Rheumatology & Autoimmunity 5, no. 1 (2025): 73. https://doi.org/10.1002/rai2.12154.

MLA (9th ed.) Citation

Feng, Ruiling, et al. "Combination Therapy with Belimumab and Low‐dose Interleukin‐2 in a Patient with Anti‐MDA5 Antibody Dermatomyositis Overlapping with Systemic Lupus Erythematosus." Rheumatology & Autoimmunity, vol. 5, no. 1, 2025, p. 73, https://doi.org/10.1002/rai2.12154.